Curaleaf Holdings (CURLF) Intangibles (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Intangibles of $1.0 billion for Q4 2025, down 6.84% year-on-year from $1.1 billion in Q4 2024, and down 6.84% on a QoQ basis from $1.1 billion in Q4 2024.
Curaleaf Holdings (CURLF) Intangibles (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Intangibles for 7 consecutive years, with $1.0 billion the latest figure, recorded in Q4 2025.
- Quarterly Intangibles fell 6.84% year-over-year to $1.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (down 6.84% YoY) and the FY2025 annual result came in at $1.0 billion, down 6.84% from the prior year.
- Intangibles declined to $1.0 billion in Q4 2025 per CURLF's latest filing, from $1.1 billion in the prior quarter.
- Over the last five years, Intangibles for CURLF reached as high as $1175.8 billion in Q1 2022 and fell as low as $781.1 million in Q1 2021.
- A 5-year average of $79.4 billion and a median of $1.1 billion in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles soared 150425.73% — and 2024, when it decreased 7.42%.
- Year by year, Intangibles stood at $1.0 billion in 2021, then gained by 17.11% to $1.2 billion in 2022, then slipped by 3.37% to $1.2 billion in 2023, then retreated by 7.42% to $1.1 billion in 2024, then dropped by 6.84% to $1.0 billion in 2025.
- According to Business Quant data, Intangibles over the past three periods registered $1.0 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.17 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 1.15 Bn |
| Mar 31, 2022 | 1,175.77 Bn |
| Dec 31, 2021 | 1.04 Bn |
| Sep 30, 2021 | 1.11 Bn |
| Jun 30, 2021 | 1.12 Bn |
| Mar 31, 2021 | 781.11 Mn |
| Dec 31, 2020 | 707.63 Mn |
| Sep 30, 2020 | 806.75 Mn |
| Dec 31, 2019 | 185.64 Mn |